Page last updated: 2024-08-24

adefovir dipivoxil and Bright Disease

adefovir dipivoxil has been researched along with Bright Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, H; Qiu, L; Xiao, P; Yuan, X; Zhou, Q1
Dong, H; Guan, GJ; Jiang, W; Liu, LQ; Liu, T; Liu, XC; Xu, Y1
Chen, YS; Jin, ZJ; Li, DF; Qiao, LM; Zhou, J1

Trials

1 trial(s) available for adefovir dipivoxil and Bright Disease

ArticleYear
[Adefovir dipivoxil treatment of hepatic cirrhosis complicated with hepatitis B virus associated glomerulonephritis].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2008, Volume: 16, Issue:5

    Topics: Adenine; Adolescent; Adult; Antiviral Agents; Female; Glomerulonephritis; Hepatitis B; Hepatitis B virus; Humans; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Young Adult

2008

Other Studies

2 other study(ies) available for adefovir dipivoxil and Bright Disease

ArticleYear
Efficacy of adefovir dipivoxil combined with a corticosteroid in 38 cases of nephrotic syndrome induced by hepatitis B virus-associated glomerulonephritis.
    Renal failure, 2014, Volume: 36, Issue:9

    Topics: Adenine; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Glomerulonephritis; Glucocorticoids; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Nephrotic Syndrome; Organophosphonates; Treatment Outcome; Young Adult

2014
Relationship Between Serum DNA Replication, Clinicopathological Characteristics and Prognosis of Hepatitis B Virus-associated Glomerulonephritis with Severe Proteinuria by Lamivudine Plus Adefovir Dipivoxil Combination Therapy.
    Biomedical and environmental sciences : BES, 2015, Volume: 28, Issue:3

    Topics: Adenine; Adult; Aged; Antiviral Agents; DNA Replication; DNA, Viral; Drug Therapy, Combination; Female; Glomerulonephritis; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prognosis; Proteinuria; Young Adult

2015